Insmed valuation
$121.86Change from previous close: −0.83%Absolute change: −$1.02
Valuation
The average price target of 22 analysts is $194.18.
Data as of November 17, 2026
Insmed compared with similar companies
Insmed's Forward P/E: 186.7, +1,090% against the median of a group of 8 similar companies (15.7).
| Metric | Insmed | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Forward P/E | 186.7 | 15.7 | 13.4 – 26.9 | High |
| Price/book | 37.1 | 7.12 | 4.45 – 9.96 | High |
| Price/sales | 17.7 | 7.99 | 4.99 – 15.2 | High |
| Gross margin | 84.4% | 84.4% | 66.4% – 91.5% | Middle |
| Operating margin | -41.7% | 19.5% | -48.6% – 31.6% | Middle |
| Net margin | -39.9% | 6.7% | 0.0% – 30.6% | Low |
| ROE | -72.5% | 7.8% | -8.3% – 31.4% | Low |
| Debt/equity | 1.01 | 0.35 | 0.06 – 0.85 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $26.96B
- Enterprise value
- $26.54B
- PEG
- 1.09
- EV/EBITDA
- -43.4
- EV/revenue
- 17.5
Profitability and growth
- ROA
- -17.3%
- Revenue growth (year over year)
- 268.4%
Financial health
- Total cash
- $1.15B
- Total debt
- $730.94M
- Current ratio
- 2.86
- Quick ratio
- 2.36
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $194.18
- Median price target
- $195.00
- High price target
- $243.00
- Low price target
- $158.00
- Analysts with a price target
- 22
- Consensus
- Strong buy
- Forward EPS
- $0.66
- EPS estimate, current year
- -$1.67
Shares and trading
- Beta
- 0.81
- Average volume
- 2.78M
- Shares outstanding
- 219.38M
- Float
- 217.93M
- Institutional ownership
- 104.5%
- Insider ownership
- 1.0%
- Short interest (% of float)
- 7.2%
- Short ratio (days)
- 3.83
